Speaker illustration

Doctor Afnan Tariq

New York University Langone Medical Center, New York (United States of America)

Member of:

European Society of Cardiology
EAPCI

Dr. Tariq is a Clinical Instructor in Interventional Cardiology at New York University Langone Health. He previously completed Interventional Cardiology training at Lenox Hill Hospital in New York City, and Cardiology at the University of California Irvine. He is currently pursuing advanced work in Structural Heart Disease at NYU Langone. He is active in coronary, peripheral, and structural interventions. His academic interests include coronary physiology and imaging, complex coronary and peripheral interventions, complex structural interventions, and clinical and outcomes research.

The impact of intravascular ultrasound and optical coherence tomography during percutaneous coronary intervention on clinical outcomes, costs, and readmissions in the USA

Event: ESC Congress 2018

Topic: Intracoronary Ultrasound

Session: Coronary physiology and beyond

Thumbnail

The impact of BMI on clinical outcomes and readmissions after surgical and transcatheter aortic valve replacement in the USA

Event: ESC Congress 2018

Topic: Intervention

Session: Deep dive in TAVI

Thumbnail

Takotsubo cardiomyopathy in the USA: clinical outcomes and readmissions in 2013

Event: ESC CONGRESS 2017

Topic: Prognosis

Session: Cardiomyopathies: understanding the enemy

Thumbnail

Impact of BMI on clinical outcomes and readmissions after cardiac catheterization in the USA

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session: PCI - Long-term outcome

Thumbnail

Trends in diagnosis of dressler's syndrome in the united states from 2003-2013

Event: ESC CONGRESS 2016

Topic: Post infarction period

Session: Long-term out come after myocardial infarction

Thumbnail

Trends in percutaneous coronary angioplasty (PTCA) in the United States, 2003-2013

Event: ESC CONGRESS 2016

Topic: PCI: primary PCI / patient subsets

Session: Best Posters in PCI strategies

Thumbnail

This platform is supported by

logo Novo Nordisk